We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...
Positive topline data for CAN-2409 viral immunotherapy achieved primary endpoint by demonstrating statistically significant and clinically meaningful benefit when combined with radiation therapy...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.3579 | 76.9772133327 | 4.3622 | 14.6 | 4.28 | 20494517 | 7.67024839 | CS |
4 | 3.5601 | 85.5793269231 | 4.16 | 14.6 | 3.785 | 5869578 | 7.4204428 | CS |
12 | -0.2799 | -3.49875 | 8 | 14.6 | 3.785 | 2066830 | 7.30126203 | CS |
26 | -0.0499 | -0.642213642214 | 7.77 | 14.6 | 3.785 | 1154621 | 7.12084296 | CS |
52 | 6.3751 | 473.985130112 | 1.345 | 14.6 | 1 | 2146047 | 6.50270536 | CS |
156 | -1.0699 | -12.1717861206 | 8.79 | 14.6 | 0.66 | 739034 | 6.39992496 | CS |
260 | -0.2799 | -3.49875 | 8 | 14.78 | 0.66 | 667428 | 6.44833083 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions